alexa Of Pregnant Women And Mice: Maternal-fetal Disposition Of Glyburide During Pregnancy And Implications For The Treatment Of Gestational Diabetes Mellitus
ISSN: 2155-6156

Journal of Diabetes & Metabolism
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

5th World Congress on Diabetes & Metabolism
November 03-05, 2014 Embassy Suites Las Vegas, USA

Qingcheng Mao
ScientificTracks Abstracts: J Diabetes Metab
DOI: 10.4172/2155-6156.S1.026
Gestational diabetes mellitus is a major complication of human pregnancy. The clearance (CL) of glyburide, an oral antidiabetic drug, increases 2-fold in pregnant women during late gestation versus non-pregnant controls. However, the mechanism behind this pharmacokinetic change has not been fully understood. Therefore, in the present study,we examined gestational age-dependent changes in maternal-fetal pharmacokinetics (PK) of glyburide and metabolites in a pregnant mouse models. Non-pregnant and pregnant FVB mice were given glyburide by retro-orbital injection. Maternal plasma was collected over 240 min on gestation days (gd) 0, 7.5, 10, 15 and 19; fetuses were collected on gd 15 and 19. Glyburide and metabolites were quantified using HPLC-MS, and PK analyses were performed using a pooled data bootstrap approach. It was found that maternal CL of glyburide increased ~50% on gd 10, 15, and 19 compared to non-pregnant controls. Intrinsic clearance (CLint) of glyburide in maternal liver microsomes also increased as gestation progressed. Although total fetal exposure to glyburide was < 5% of maternal plasma exposure, it doubled on gd 19 compared to gd 15. This is the first evidence of gestational age-dependent changes in glyburide PK. Increased glyburide clearance during pregnancy is attributable to increased hepatic metabolism. In the mouse model, fetal exposure to glyburide is gestational age-dependent, which can be explained by gestational-age dependent expression in the placenta of BCRP, a drug transporter that mediates efflux of glyburide from the fetal compartment back to the maternal circulation. These results suggest that adjusting maternal glyburide dosing regimens according to gestational age should be considered to achieve optimal efficacy and safety of the drug if the same PK changes occur in pregnant women.
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version